Xu Zhenyu 4
4 · SOPHiA GENETICS SA · Filed Apr 8, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CSO Xu Zhenyu Sells Shares
What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS (SOPH), sold a total of 5,100 shares in two open-market transactions: 2,700 shares on 2026-04-06 at a weighted average price reported as $4.85 (proceeds $13,100) and 2,400 shares on 2026-04-07 at a weighted average price reported as $4.87 (proceeds $11,679). These were sales to satisfy tax-withholding obligations tied to recent restricted stock unit vesting and were executed under a pre-established Rule 10b5-1 trading plan (routine, non-discretionary).
Key Details
- Transaction dates and reported weighted-average prices:
- 2026-04-06 — 2,700 shares sold, $4.85 (reported), proceeds $13,100. (See footnote F2: actual prices ranged $4.67–$4.95.)
- 2026-04-07 — 2,400 shares sold, $4.87 (reported), proceeds $11,679. (See footnote F3: actual prices ranged $4.69–$4.98.)
- Total shares sold: 5,100; total proceeds reported: $24,779.
- Purpose: Sales were made to satisfy tax withholding on RSU vesting (vest dates April 2 and 3, 2026) and were effected under a pre-established Rule 10b5-1 plan (footnote F1).
- Shares owned after the transactions: Not specified in the provided filing excerpt.
- Filing: Form 4 filed with the SEC on 2026-04-08; no late-filing indication shown in the provided information.
Context
These transactions were tax-withholding sales under a 10b5-1 plan, which are generally considered routine and do not necessarily indicate a change in insider sentiment. The filing reports weighted-average prices and includes footnotes offering to provide per-trade price breakdowns on request.
Insider Transaction Report
- Sale
Ordinary Shares
[F1][F2]2026-04-06$4.85/sh−2,700$13,100→ 647,352 total - Sale
Ordinary Shares
[F1][F3]2026-04-07$4.87/sh−2,400$11,679→ 644,952 total
Footnotes (3)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on April 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.67 to $4.95, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.69 to $4.98, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.